These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25650661)

  • 1. Farnesoid X receptor associates with β-catenin and inhibits its activity in hepatocellular carcinoma.
    Liu X; Zhang X; Ji L; Gu J; Zhou M; Chen S
    Oncotarget; 2015 Feb; 6(6):4226-38. PubMed ID: 25650661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activation of the Wnt/β-catenin pathway in spontaneous hepatocellular carcinoma observed in farnesoid X receptor knockout mice.
    Wolfe A; Thomas A; Edwards G; Jaseja R; Guo GL; Apte U
    J Pharmacol Exp Ther; 2011 Jul; 338(1):12-21. PubMed ID: 21430080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
    Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
    Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W; Chua MS; Grepper S; So S
    Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
    Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
    Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
    Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F
    Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
    J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.
    Hua HW; Jiang F; Huang Q; Liao Z; Ding G
    Oncotarget; 2015 Feb; 6(6):3840-7. PubMed ID: 25708809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
    Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
    Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
    Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.
    Martinez-Becerra P; Vaquero J; Romero MR; Lozano E; Anadon C; Macias RI; Serrano MA; Grañé-Boladeras N; Muñoz-Bellvis L; Alvarez L; Sangro B; Pastor-Anglada M; Marin JJ
    Mol Pharm; 2012 Jun; 9(6):1693-704. PubMed ID: 22524153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.
    Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z
    Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic STRAP Supports Hepatocellular Carcinoma Growth by Enhancing Wnt/β-Catenin Signaling.
    Wang W; Li S; Liu P; Sideras K; van de Werken HJG; van der Heide M; Cao W; Lavrijsen M; Peppelenbosch MP; Bruno M; Pan Q; Smits R
    Mol Cancer Res; 2019 Feb; 17(2):521-531. PubMed ID: 30257989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 4-phosphate adaptor protein 2 accelerates the proliferation and invasion of hepatocellular carcinoma cells by enhancing Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    J Bioenerg Biomembr; 2020 Oct; 52(5):301-309. PubMed ID: 32914361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.